Evaluate the Safety, Tolerability, and Efficacy of ICP-490 in Patients with Relapsed or Refractory Non-Hodgkin Lymphoma

Study of IMM0306 in Patients With Relapsed or Refractory CD20-positive B-cell Non-Hodgkin's Lymphoma

NCT05805943 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2

Efficacy and Safety Evaluation of IBI308 in Treatment of Patients With Relapsed/Refractory Classical Hodgkin's Lymphoma

NCT03114683 ·Status: COMPLETED ·Phase: PHASE2

A Study to Assess Safety and Efficacy of CHO-H01 as a Single Agent/Combined With Lenalidomide in Subjects With Refractory or Relapsed Non-Hodgkin's Lymphoma

NCT05950165 ·Status: RECRUITING ·Phase: PHASE1/PHASE2

Recombinant Humanized Anti-CD47/PD-1 Bifunctional Antibody HX009 in Patients With Relapsed/Refractory Lymphoma

NCT05189093 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

A Study of GFH009 Monotherapy in Patients with Relapsed or Refractory Peripheral T-cell Lymphoma (PTCL)

NCT05934513 ·Status: RECRUITING ·Phase: PHASE1/PHASE2

GVM±R in Patients With Relapsed or Refractory Aggressive NHL

NCT05299164 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1

A Trial of the Safety of Escalating Doses of PRO131921 in Patients With Relapsed or Refractory Indolent Non-Hodgkin's Lymphoma

NCT00452127 ·Status: TERMINATED ·Phase: PHASE1/PHASE2

A Phase III Study to Evaluate the Efficacy and Safety of Penpulimab in the Relapsed and Refractory Classical Hodgkin's Lymphoma

NCT05244642 ·Status: RECRUITING ·Phase: PHASE3

A Study of Liposome-entrapped Mitoxantrone Hydrochloride Injection in Relapsed/Refractory Peripheral T-cell Lymphoma and NK/T-cell Lymphoma

NCT03776279 ·Status: UNKNOWN ·Phase: PHASE2

A Study of Anti-PD-1 AK105 in Patients With Relapsed or Refractory Classic Hodgkin Lymphoma

NCT03722147 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

A Study of YY-20394 in Participants With Relapsed/Refractory Follicular Non-Hodgkin's Lymphoma

NCT04370405 ·Status: UNKNOWN ·Phase: PHASE2

Lenalidomide and Ibrutinib in Treating Patients With Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma

NCT01955499 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1

Phase II Clinical Trial of CNCT19 Cell Injection in the Treatment of Relapsed or Refractory Non-Hodgkin's Lymphoma

NCT04586478 ·Status: RECRUITING ·Phase: PHASE2

A Multicenter Clinical Study on the Safety and Efficacy of CAR-T in the Treatment of Relapsed / Refractory Non Hodgkin's Lymphoma

NCT04666168 ·Status: UNKNOWN ·Phase: NA

IBI376 in Patients With Relapsed or Refractory Follicular Lymphoma/Marginal Zone Lymphoma

NCT04298879 ·Status: COMPLETED ·Phase: PHASE2

Study of PD-1 Monoclonal Antibody in Combination With Chemotherapy in Patients With RR NHL

NCT04134247 ·Status: UNKNOWN ·Phase: PHASE4

A Phase 2 Clinical Study of YY-20394 in Patients With Relapsed/Refractory Follicular Lymphoma

NCT04379167 ·Status: UNKNOWN ·Phase: PHASE2

IMGN529 in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia

NCT01534715 ·Status: COMPLETED ·Phase: PHASE1

Camrelizumab Plus Decitabine in Anti-PD-1 Treatment-naive Patients With Relapsed/Refractory Classical Hodgkin Lymphoma

NCT04510610 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3

Study of BEBT-908 in the Relapsed or Refractory Diffuse Large B-cell Lymphoma Subjects

NCT06074107 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

A Phase II Study of Linperlisib (YY-20394) in Patients With Relapsed or Refractory Peripheral T/NK Cell Lymphoma

NCT05274997 ·Status: UNKNOWN ·Phase: PHASE2

APG-1252 Monotherapy or in Combination With Other Therapeutic Agent in Subjects With Relapsed or Refractory Non-Hodgkin Lymphoma

NCT05186012 ·Status: RECRUITING ·Phase: PHASE1/PHASE2

Phase 2 Study With PQR309 in Relapsed or Refractory Lymphoma Patients

NCT03127020 ·Status: COMPLETED ·Phase: PHASE2

A Study Evaluating Safety and Efficacy of C-CAR039 Treatment in NHL Subjects

NCT04317885 ·Status: COMPLETED ·Phase: PHASE1

GVM±R in Patients With Relapsed or Refractory Aggressive NHL.

NCT06244368 ·Status: RECRUITING ·Phase: PHASE2